Header Logo

Connection

ANNE TSAO to Antibodies, Bispecific

Back to Details
This is a "connection" page, showing publications ANNE TSAO has written about Antibodies, Bispecific.
ANNE TSAO
Connection Strength
0.169
Antibodies, Bispecific
  1. Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC. J Thorac Oncol. 2024 03; 19(3):500-506.
    View in: PubMed
    Score: 0.169
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.